SCHEDULE 13G/A: Frederic H. Moll Discloses 10.6% Beneficial Ownership in SS Innovations International, Inc.
Beneficial Ownership Report
Frederic H. Moll has filed an amended Schedule 13G, reporting a beneficial ownership of 10.6% in SS Innovations International, Inc. as of December 31, 2024.
Summary
- Frederic H. Moll, the Reporting Person, beneficially owns an aggregate of 18,147,547 shares of common stock in SS Innovations International, Inc.
- This aggregate amount represents 10.6% of the company's common stock outstanding.
- The ownership is calculated based on 170,873,415 shares of common stock outstanding as of January 14, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.
- Of the total shares, 16,689,821 shares are held with sole voting and sole dispositive power.
- The sole power shares include 10,724,232 shares held directly by Mr. Moll and 6,415,589 shares held by the Frederic Hutchins Moll Revocable Trust, where Mr. Moll has a 100% interest.
- An additional 1,457,726 shares are held with shared voting and shared dispositive power through Sonder Futures II, L.P., where Mr. Moll is a member of the general partner.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook. The presence of a significant investor can be seen as a neutral to slightly positive signal.
Positives
- The disclosure of a significant beneficial ownership stake (10.6%) by Frederic H. Moll, a notable figure in the medical technology industry, may signal confidence in SS Innovations International, Inc.'s long-term prospects.
Industry Context
This filing is a standard regulatory disclosure of significant ownership and does not provide specific industry context or trends. However, Frederic H. Moll's background in medical technology (co-founder of Intuitive Surgical) suggests his investment is likely related to the company's activities in that sector.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a prominent individual investor may instill confidence among existing and potential shareholders, potentially influencing investor sentiment and stock valuation.
Key Dates
| Date | Description |
|---|---|
| 2023-09-30 | End of quarter for which the issuer's Form 10-Q reported shares outstanding. |
| 2024-12-31 | Date of event which requires filing of this statement (beneficial ownership snapshot). |
| 2025-01-14 | Date as of which 170,873,415 shares of common stock were reported outstanding for calculation purposes. |
| 2025-02-12 | Date the Schedule 13G/A was signed and filed. |
Keywords
SS Innovations International, Frederic H. Moll, Schedule 13G, beneficial ownership, common stock, Sonder Futures II, SEC filing, institutional ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.